most effective glp-1 for obesity treatment 2025 Market Size to Hit USD 66.57 Billion by 2035 Poll: 1 in 8 Adults

In fact, the GLP-1 market was valued at $16.53 billion in 2021 and is expected to reach a whopping $24.10 billion by 2027

(2) What does this mean for food companies

This could be another reason why you may want to consider tirzepatide vs semaglutide for weight loss

Other side effects are rare and do not happen due to discontinuation of the drug

Getting emotional support if weaning feels sudden, unwanted, or complicated

Currently, multiple phase 3 trials with oral semaglutide and orforglipron are ongoing for different populations (NCT05803421), while another oral GLP-1 RA (CT-996) is in early phase clinical trials (Table 1)